Capsule, hard
Trade Name
Lyrgaba
150 mg
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Indicated for
- Treatment of Peripheral and central neuropathic pain in adults.
- As adjunctive therapy in adults with partial seizures with or without secondary generalisation.
- Treatment of Generalised Anxiety Disorder (GAD) in adults.
- Treatment of Peripheral and central neuropathic pain in adults.
- As adjunctive therapy in adults with partial seizures with or without secondary generalisation.
- Treatment of Generalised Anxiety Disorder (GAD) in adults.